摘要
Laryngeal squamous cell cancer (LSCC) is the second most prevalent malignancy occurring in the head and neck with a high incidence and mortality rate. Immunotherapy has recently become an emerging treatment for cancer. It is therefore essential to explore the role of tumour immunity in laryngeal cancer. Our study first delineated and evaluated the comprehensive immune infiltration landscapes of the tumour microenvironment in LSCC. A hierarchical clustering method was applied to classify the LSCC samples into two groups (high- and low-infiltration groups). We found that individuals with low immune infiltration characteristics had significantly better survival than those in the high-infiltration group, possibly because of the elevated infiltration of immune suppressive cells, such as regulatory T cells and myeloid-derived suppressor cells, in the high-infiltration group. Differentially expressed genes between two groups were involved in some immune-related terms, such as antigen processing and presentation. A univariate Cox analysis and least absolute shrinkage and selection operator analysis were performed to identify an immune gene-set-based prognostic signature (IBPS) to assess the risk of LSCC. The prognostic model comprising six IBPSs was successfully verified to be robust in different cohorts. The expression of the six IBPSs was detected by immunohistochemistry in 110 cases of LSCC. In addition, different inflammatory profiles and immune checkpoint landscape of LSCC were found between two groups. Hence, our model could serve as a candidate immunotherapeutic biomarker and potential therapeutic target for laryngeal cancer.
学科与关键词
- Assessment of immune status of laryngeal squamous cell carcinoma can predict prognosis and guide treatmentWang, Xueying; Cao, Kui; Guo, Erliang; Mao, Xionghui; An, Changming; Guo, Lunhua; Zhang, Cong; Guo, Junnan; Yang, Xianguang; Sun, Ji; Yang, Weiwei; Li, Xiaomei*; Miao, Susheng*Cancer Immunology, Immunotherapy, 2022, 71(5): 1199-1220.被引 10
- Model establishment of prognostic-related immune genes in laryngeal squamous cell carcinomaMing, Sun; Sihan, Chen; Min, FuMedicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2021, 100(2): e24263.
- A novel comprehensive immune-related gene signature as a promising survival predictor for the patients with head and neck squamous cell carcinomaFang, Ruihua; Iqbal, Muhammad; Chen, Lin; Liao, Jing; Luo, Jierong; Wei, Fanqin; Wen, Weiping*; Sun, Wei*Aging-US, 2021, 13(8): 11507-11527.被引 4
